No correlation between response and survival in patients with multiple myeloma treated with vincristine, melphalan, cyclophosphamide, and prednisone

This publication has 24 references indexed in Scilit:

• Melphalan/prednisone versus drug combinations for plasma cell myeloma
  European Journal of Haematology, 1989
• Are the current criteria for response useful in the management of multiple myeloma?
  Journal of Clinical Oncology, 1987
• Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents
  New England Journal of Medicine, 1984
• Synthesis and Metabolism of Bence Jones Protein and Calculation of Tumour Burden in Patients with Bence Jones Myeloma
  British Journal of Haematology, 1981
• The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute Leukemia
  New England Journal of Medicine, 1979
• Improved survival of increased-risk myeloma patients on combined triple- alkylating-agent therapy: a study of the CALGB
  Blood, 1979
• Combination therapy for multiple myeloma
  Cancer, 1977
• A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
  Cancer, 1975
• Combination chemotherapy for multiple myeloma
  Cancer, 1972
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958